MA28111A1 - Derives des - Google Patents
Derives desInfo
- Publication number
- MA28111A1 MA28111A1 MA28965A MA28965A MA28111A1 MA 28111 A1 MA28111 A1 MA 28111A1 MA 28965 A MA28965 A MA 28965A MA 28965 A MA28965 A MA 28965A MA 28111 A1 MA28111 A1 MA 28111A1
- Authority
- MA
- Morocco
- Prior art keywords
- mch
- anxiety
- obesity
- diabetes
- depression
- Prior art date
Links
- 208000019901 Anxiety disease Diseases 0.000 abstract 2
- 102400001132 Melanin-concentrating hormone Human genes 0.000 abstract 2
- 101800002739 Melanin-concentrating hormone Proteins 0.000 abstract 2
- 208000008589 Obesity Diseases 0.000 abstract 2
- 230000036506 anxiety Effects 0.000 abstract 2
- 206010012601 diabetes mellitus Diseases 0.000 abstract 2
- 235000020824 obesity Nutrition 0.000 abstract 2
- LVAGVGLOKJYPSZ-UHFFFAOYSA-N 3-(4-aminophenyl)thieno[3,2-d]pyrimidin-4-one Chemical class C1=CC(N)=CC=C1N1C(=O)C(SC=C2)=C2N=C1 LVAGVGLOKJYPSZ-UHFFFAOYSA-N 0.000 abstract 1
- 229940123502 Hormone receptor antagonist Drugs 0.000 abstract 1
- 102000029828 Melanin-concentrating hormone receptor Human genes 0.000 abstract 1
- 108010047068 Melanin-concentrating hormone receptor Proteins 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 150000004982 aromatic amines Chemical class 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Neurology (AREA)
- Hematology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Child & Adolescent Psychology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Dérivés de 3-(4-aminophényl)-thiénopyrimid-4-one servant d'antagonistes de MCH R1 pour le traitement de l'obésité, du diabète, de la dépression et de l'anxiété La présente invention concerne des arylamines nouvelles qui sont des antagonistes du récepteur 1 de l'hormone concentrant la mélanine (MCH R1), des compositions pharmaceutiques les contenant, des procédés pour leur préparation, et leur utilisation dans des médicaments pour le traitement de l'obésité, du diabète, de la dépression et/ou de l'anxiété. Les composés de la présente invention répondent à la formule:
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US51380003P | 2003-10-23 | 2003-10-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA28111A1 true MA28111A1 (fr) | 2006-08-01 |
Family
ID=34549304
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA28965A MA28111A1 (fr) | 2003-10-23 | 2006-04-25 | Derives des |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20070078125A1 (fr) |
| EP (1) | EP1678184A1 (fr) |
| JP (1) | JP2007509158A (fr) |
| KR (1) | KR20060100412A (fr) |
| CN (1) | CN1871242A (fr) |
| AU (1) | AU2004285913A1 (fr) |
| BR (1) | BRPI0415667A (fr) |
| CA (1) | CA2543122A1 (fr) |
| CO (1) | CO5690599A2 (fr) |
| IL (1) | IL174693A0 (fr) |
| MA (1) | MA28111A1 (fr) |
| MX (1) | MXPA06003997A (fr) |
| NO (1) | NO20061909L (fr) |
| WO (1) | WO2005042541A1 (fr) |
| ZA (1) | ZA200603181B (fr) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080221107A1 (en) * | 2005-07-15 | 2008-09-11 | Astrazeneca Ab | Therapeutic Agents |
| JP4870163B2 (ja) | 2005-09-30 | 2012-02-08 | エフ.ホフマン−ラ ロシュ アーゲー | Mch受容体アンタゴニストとしてのインダン誘導体 |
| US7745447B2 (en) | 2005-10-26 | 2010-06-29 | Bristol-Myers Squibb Company | Substituted thieno[3,2-D]pyrimidines as non-basic melanin concentrating hormone receptor-1 antagonists |
| US8618115B2 (en) * | 2005-10-26 | 2013-12-31 | Bristol-Myers Squibb Company | Substituted thieno[3,2-d]pyrimidinones as MCHR1 antagonists and methods for using them |
| ES2412007T3 (es) | 2005-12-21 | 2013-07-09 | Janssen Pharmaceutica, N.V. | Derivados de pirazinona sustituida novedosos para uso en enfermedades mediadas por MCH-1 |
| US7553836B2 (en) * | 2006-02-06 | 2009-06-30 | Bristol-Myers Squibb Company | Melanin concentrating hormone receptor-1 antagonists |
| AU2007214708A1 (en) * | 2006-02-15 | 2007-08-23 | Sanofi-Aventis | Novel azacycly-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments |
| AU2007214710A1 (en) | 2006-02-15 | 2007-08-23 | Sanofi-Aventis | Novel amino alcohol-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments |
| RU2008136898A (ru) * | 2006-02-15 | 2010-03-20 | Санофи-Авентис (Fr) | Азациклил-замещенные арилдигидроизохинолиноны, способ их получения и их применение в качестве лекарственных средств |
| CA2636617A1 (fr) * | 2006-02-15 | 2007-08-23 | Lothar Schwink | Nouvelles aryldihydroisoquinolinones a substitution amino-alcool, procede pour les preparer et leur utilisation en tant que medicaments |
| CA2652385A1 (fr) * | 2006-06-08 | 2007-12-21 | Eli Lilly And Company | Nouveaux antagonistes de recepteur de mch |
| JP2010501553A (ja) * | 2006-08-18 | 2010-01-21 | アストラゼネカ アクチボラグ | Mchr1アンタゴニストとしてのチエノピリミジン−4−オン誘導体およびチエノピリダジン−7−オン誘導体 |
| WO2008086404A1 (fr) | 2007-01-10 | 2008-07-17 | Albany Molecular Research, Inc. | Indazoles 5-pyridinone substituées |
| US7851622B2 (en) | 2007-04-25 | 2010-12-14 | Bristol-Myers Squibb Company | Non-basic melanin concentrating hormone receptor-1 antagonists |
| CN101861311A (zh) | 2007-07-21 | 2010-10-13 | 阿尔巴尼分子研究公司 | 5-吡啶酮取代的吲唑 |
| PE20091928A1 (es) | 2008-05-29 | 2009-12-31 | Bristol Myers Squibb Co | Tienopirimidinas hidroxisustituidas como antagonistas de receptor-1 de hormona concentradora de melanina no basicos |
| EP2406233B1 (fr) | 2009-03-09 | 2013-11-13 | Bristol-Myers Squibb Company | Analogues d'aza-pyridone utiles en tant que antagonistes des récepteurs de l'hormone concentrant la mélanine |
| HUP1100241A3 (en) | 2011-05-06 | 2013-12-30 | Richter Gedeon Nyrt | Oxetane substituted pyrimidones |
| KR20130013199A (ko) * | 2011-07-27 | 2013-02-06 | 한미약품 주식회사 | 신규 피리미딘 유도체 및 이를 활성성분으로 포함하는 약학 조성물 |
| DK2747693T3 (en) | 2011-08-26 | 2018-07-02 | On Light Sciences Inc | SYSTEM AND PROCEDURE FOR TATTOO REMOVAL |
| AU2021206286A1 (en) * | 2020-01-10 | 2024-08-08 | Consynance Therapeutics, Inc. | Therapeutic combinations of drugs and methods of using them |
| HUP2200222A1 (hu) | 2022-06-17 | 2023-12-28 | Richter Gedeon Nyrt | MCHR1 antagonisták a Prader-Willi szindróma kezelésére |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0124627D0 (en) * | 2001-10-15 | 2001-12-05 | Smithkline Beecham Plc | Novel compounds |
-
2004
- 2004-10-21 JP JP2006536779A patent/JP2007509158A/ja active Pending
- 2004-10-21 US US10/576,765 patent/US20070078125A1/en not_active Abandoned
- 2004-10-21 EP EP04795941A patent/EP1678184A1/fr not_active Withdrawn
- 2004-10-21 BR BRPI0415667-6A patent/BRPI0415667A/pt not_active IP Right Cessation
- 2004-10-21 CA CA002543122A patent/CA2543122A1/fr not_active Abandoned
- 2004-10-21 AU AU2004285913A patent/AU2004285913A1/en not_active Abandoned
- 2004-10-21 MX MXPA06003997A patent/MXPA06003997A/es unknown
- 2004-10-21 KR KR1020067009417A patent/KR20060100412A/ko not_active Withdrawn
- 2004-10-21 CN CNA2004800313000A patent/CN1871242A/zh active Pending
- 2004-10-21 WO PCT/US2004/034846 patent/WO2005042541A1/fr not_active Ceased
-
2006
- 2006-03-30 IL IL174693A patent/IL174693A0/en unknown
- 2006-04-20 ZA ZA200603181A patent/ZA200603181B/en unknown
- 2006-04-21 CO CO06038136A patent/CO5690599A2/es not_active Application Discontinuation
- 2006-04-25 MA MA28965A patent/MA28111A1/fr unknown
- 2006-04-28 NO NO20061909A patent/NO20061909L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO20061909L (no) | 2006-05-03 |
| EP1678184A1 (fr) | 2006-07-12 |
| MXPA06003997A (es) | 2006-07-05 |
| ZA200603181B (en) | 2008-01-30 |
| CO5690599A2 (es) | 2006-10-31 |
| JP2007509158A (ja) | 2007-04-12 |
| US20070078125A1 (en) | 2007-04-05 |
| WO2005042541A1 (fr) | 2005-05-12 |
| IL174693A0 (en) | 2006-08-20 |
| CA2543122A1 (fr) | 2005-05-12 |
| KR20060100412A (ko) | 2006-09-20 |
| AU2004285913A1 (en) | 2005-05-12 |
| BRPI0415667A (pt) | 2006-12-19 |
| CN1871242A (zh) | 2006-11-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA30539B1 (fr) | Derives de piperazinyle utiles dans le traitement de maladies induites par le recepteur gpr38. | |
| ATE422887T1 (de) | Kondensierte heterozyklische verbindungen | |
| MA29693B1 (fr) | Derives de xanthine en tant qu'agonistes hm74a selectifs | |
| ATE423769T1 (de) | Fluor- und sulfonylaminohaltige, 3,6- disubstituierte azabicyclo 3.1.0 hexanderivate als muscarinrezeptorantagonisten | |
| SE9902987D0 (sv) | Novel compounds | |
| HUP0100266A2 (hu) | NMDA-receptor-antagonista hatású 1-aminoalkilciklohexánszármazékok, a vegyületeket tartalmazó gyógyszerkészítmények és előállításaik | |
| PL1716152T3 (pl) | Skondensowane związki heterocykliczne i ich zastosowanie jako antagonistów receptora metabotropowego do leczenia zaburzeń żołądkowo-jelitowych | |
| TNSN08137A1 (fr) | Derives de carboxamides servant d'antagonistes des recepteurs muscariniques | |
| MA26722A1 (fr) | Nouveaux composes et medicaments les contenant | |
| TR200504337T1 (tr) | Imatinib mezilat'ın yeni polimorfları | |
| MA30999B1 (fr) | Composés. | |
| MA30778B1 (fr) | Derives de sulfonamides servant d'agonistes adrenergique et d'antagonistes muscariniques | |
| MA30289B1 (fr) | Dérivés d'amines | |
| EP1641423A4 (fr) | Antagonistes du recepteur du cgrp de | |
| MA27448A1 (fr) | Derives de pyridine modulateurs du recepteur cb2 | |
| TW200510429A (en) | Heterocyclic MCHR1 antagonists | |
| MA27443A1 (fr) | Oxazoles et thiazoles nouveaux servant d'inhibiteurs du facteur de croissance transformant (tgf) | |
| MA30696B1 (fr) | Derives de l'acide (3-amino-1,2,3,4-tetrahydro-9h-carbazol-9-yl)-acetique | |
| DE60237528D1 (de) | Neue aminoazetidin-, aminopyrrolidin- und aminopiperidinderivative | |
| MA30077B1 (fr) | 3-aminocyclopentanecarboxamides servant de modulateurs de recepteurs de chimiokines | |
| TNSN04194A1 (fr) | Derives de tropane servant de modulateurs de ccr5 | |
| EP2042490A3 (fr) | Dérivés du benzoimidazole comme antagonistes du recepteur Vanilloid | |
| MA31941B1 (fr) | Bis-pyridylpyridones en tant qu'antagonistes du récepteur 1 de l'hormone de concentration de la mélanine | |
| TR200402529T4 (tr) | Yeni Fenalliloksi fenil türevleri. | |
| DE60226906D1 (de) | 3,6-disubstituierte azabicyclo ä3.1.0ühexanderivate, die sich als muscarinrezeptorantagonisten eignen |